How Mela works
Skincare is mostly guesswork on a long delay: you change three things, wait a month, and still can't say which one helped. I watch your skin closely enough, and long enough, to tell signal from coincidence.
What one photo tells me.
One photo isn't one number to me. I read it in layers: the surface, its oil, tone, and texture; the barrier underneath, and how fast it recovers; the vascular layer, where redness and reactivity live. Then I fold in what a photo can't show: your sleep, your cycle phase, the weather around you. Every layer, for each part of your face, tracked over time. It all feeds a stack of models, each weighted by how well it has predicted real skin, and what survives is your read.
I trust the models that have earned it.
I run thirty-five models, each a different way of reading change over time. They don't always agree, so I lean on the ones that have earned it: every model carries a weight set by how well it predicted real skin. A pattern-matcher right a quarter of the time doesn't outvote one that has been right for months.
When they agree, I read a cause.
Say a flare keeps coming back, three times, each on the cadence of your cycle. A serum you started on day 12 sits inside a clear week. In a single photo the two look identical; the timing is how I tell them apart. Nearly half of women get premenstrual flares,[1] the kind of pattern that only emerges across weeks of daily reading.
So the serum wasn't the culprit. I'd tell you to keep it, and stop changing the thing that was never the problem.
Reading timing this way lets me answer questions a single photo can't:
- Barrier recovery: how fast your skin settles after a stressor.
- Ingredient timing: whether two actives clash, from what happens in the days after they overlap.
- Cause or coincidence: whether a change really followed your routine, or only seemed to.
I read timing, where colour misleads.
Colour is exactly where reading falls down on deeper skin: the image sets behind colour-based models skew toward lighter skin, so they do worst on the skin they've seen least.[2] I read timing instead: when a signal rises, how it settles, whether it tracks an event. Timing is read against your own baseline, so melanin doesn't throw it off the way colour does. What I learn on the lightest skin holds on the darkest.
From the cause, I look ahead.
A cause is the start of a forecast. I sketch where your skin is likely headed, and I stay honest about the uncertainty: a band that widens the further out I look. It also tightens the longer we go. The more weeks I've watched you, the better I know your normal, so by month three I read you more sharply than I could in week one.
Then I name the next move.
Out of everything I could suggest, I name the one change most likely to help, then watch to see whether your skin agrees. None of this reaches you as a dashboard of model names. It arrives in plain language:
in the app, Mela says Reads like your cycle, not the new serum. Keep it.
Restraint is the point.
When one of my models can't beat a simple baseline, I bench it, and I tell you so. I'd rather say too little than overstate. What I show you is a correlation, never a verdict; a direction, never a diagnosis. That restraint is what makes the rest worth trusting.
The same months, in the medical system.
Medical care is a handful of expert moments, spaced out. Each one is a careful look. None of them can watch the weeks in between, where the timing lives, and that's the part I watch. Both rails matter; we just work at different rhythms.
Telling a serum from a cycle, over twelve weeks.
A recorded run on synthetic data, seeded so the answer is checkable: the serum was given no effect at all. Scrub the month and watch it recovered from timing alone. Under each read, the procedure line shows what I did, and did not, conclude at that step.
A recorded demonstration that scrubs twelve weeks of synthetic skin and shows how I tell a cycle flare from a new serum, from timing alone. It needs JavaScript to play. The method is in print: cause from coincidence, the cycle, not the serum, one day is not a signal. Or watch all five demonstrations.
Pick a concern. See where I stay, and where I step back.
Not everything is mine to answer. Some questions I follow over time; others belong to a doctor, and when I see one of those, my job is to notice and point you there.
Sources
- Premenstrual acne flares: of 400 women, 44% reported flares before menstruation. Stoll et al., 2001, Journal of the American Academy of Dermatology. DOI
- Underrepresentation of darker skin types in the image datasets behind dermatology image models, and worse performance on skin of color. Guo et al., 2021, Journal of the American Academy of Dermatology, DOI; see also Fliorent et al., 2024, International Journal of Dermatology, DOI.
- Routine new-patient dermatology wait: median 45 days (IQR 12–97), academic center. Jayakumar et al., 2018, Dermatology Online Journal. DOI
- National wait and insurance-based access, new and changing mole: median 7 days commercial/Medicare. Creadore et al., 2021, JAMA Dermatology. DOI
Bibliographic data via PubMed. Wait-time figures describe published study populations and vary by region, insurance, and urgency.
For where this sits in the bigger picture, there's where Mela fits alongside your dermatologist.
The methodology in practice, in the Field Notes: how Mela sorts cause from coincidence in your skincare, what skincare gets wrong about measuring your skin, and whether a new product is breaking you out — or it's your period.
Mela is a general wellness tool for tracking skin over time. It does not diagnose, treat, or provide medical advice.